Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

Roche

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.

Roche

Roche’s flu pill Xofluza gains EU approval

Roche’s flu pill Xofluza gains EU approval Swiss pharma company Roche has scored approval from the European Commission (EC) for its flu pill Xofluza. ... We are delighted that the European Commission has approved Xofluza, a first-in-class, single-dose oral medicine, for the treatment of influenza,

Biogen advances Spinraza study in SMA patients treated with Novartis’ Zolgensma

Biogen advances Spinraza study in SMA patients treated with Novartis’ Zolgensma Another competitor in the SMA market – Roche’s Evrysdi (risdiplam) – was recently approved in the US for the treatment of SMA in adults and children aged two months and older, following ... Roche has priced Evrysdi by patient weight, with a maximum

Two drugs found to reduce mortality in severe COVID-19 patients

Two drugs found to reduce mortality in severe COVID-19 patients Roche’s Actemra (tocilizumab) and Sanofi’s Kevzara (sarilumab) have been found to cut the risk of death in critically ill COVID-19 patients in a study led by Imperial College ... This includes Roche’s own phase 3 COVACTA study, in which Actemra did

Roche’s tiragolumab plus Tecentriq combo wins FDA breakthrough therapy designation

Roche’s tiragolumab plus Tecentriq combo wins FDA breakthrough therapy designation According to Roche, tiragolumab is the first anti-TIGIT molecule to win a BTD from the FDA. ... outcomes for people with certain types of lung cancer,” said Levi Garraway, chief medical officer and head of Global Product Development, Roche.

Roche gets EU approval for fixed-dose Herceptin/Perjeta combination

Roche gets EU approval for fixed-dose Herceptin/Perjeta combination The European Commission has approved a fixed dose combination of Roche’s antibody blockbusters Herceptin and Perjeta under the new brand name Phesgo. ... In Roche’s half-year report for 2020, sales of Herceptin had dropped by 28%, reflecting the

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics